Author: Shirley Creagh

prescription for medical cannabis

Dublin man becomes first patient in Ireland to be prescribed medicinal cannabis

In November 2021, Ryan Gorman (26) was the first patient in Ireland to be granted a prescription for medical cannabis through the Medical Cannabis Access Programme (MCAP).  Ryan has an aggressive form of epilepsy as well as Autism Spectrum Disorder.  He received the high CBD, low THC formula which is approved by the Primary Care Reimbursement Service (PCRS), making it free of charge.

Ryan’s father and full-time carer, Brendan Gorman spoke with BusinessCann and shared his joy on this major milestone:

“For those people out there that have been waiting so anxiously to see when I’m gonna get access to it, finally the day has arrived. It can only be described as wonderful news, and hopefully, the benefits will be there for everybody,” he said.

“It’s not about being first or being last or in the middle. What is important is that if it becomes accessible, and the barriers are broken down, it’s almost like the Berlin Wall, one goes through then the rest will follow.”

Health Minster Stephan Donnelly announced in July 2021 that medical consultants can register themselves and their patients to the MCAP through the HSE.  Patients will need to be registered before they can be prescribed cannabis-based products.  Minister Donnelly said when announcing the start of the programme:  “Today is a significant step forward in the ongoing delivery of the MCAP.

“This step forward will greatly assist patients who, under the supervision of their consultant, need to avail of medicinal cannabis products to alleviate the effects of their severe medical conditions.

“I now hope the programme continues to go on and grow and expand further, to best meet the needs of patients and families around Ireland.”

Under MCAP only a consultant can prescribe medical cannabis where conventional treatment has failed.  A poll carried out by Red C on behalf of The Journal early last year found that only 4 per cent of people were opposed to the use of medical cannabis.  Almost 1,000 adults across Ireland took part in the survey,  they weighted to be an accurate profile of the population.

The programme is only available to patients with the following medical conditions: spasticity associated with multiple sclerosis, intractable nausea and vomiting associated with chemotherapy and treatment-resistant epilepsy.

 

The endocannabinoid system and the revolution of one | Rachel Knox | TEDxPortland

DR. RACHEL KNOX, MD, MBA

Dr. Rachel Knox, MD, MBA is a cannabinoid medicine specialist and clinical endocannabinologist who received her medical and business degrees from Tufts School of Medicine after completing her undergraduate studies at Duke. She trained in family and integrative medicine before pursuing additional study in the areas of functional medicine, cannabinology, and endocannabinology.

Along with her family, Dr. Rachel founded Doctors Knox, Inc., American Cannabinoid Clinics, and Pivital Edu to advance education in cannabinoid medicine and in the clinical care of the endocannabinoidome.

Dr. Rachel is also a policy and regulatory consultant on cannabis and psychedelics, and her commitment to reform extends into educating communities of color about the roles cannabis, psychedelics, and other plant medicines can play in addressing the Minority Health Disparity Gap, and the broader way in which these plants can impact the total wellbeing of these communities through health equity.

She is co-founder and president of the Cannabis Health Equity Movement™ (CHEM), and chair of the Association for Cannabis Health Equity and Medicine (ACHEM) and CHEM Allyance. She serves her home state of Oregon as the immediate past chair of the Oregon Cannabis Commission, member of Portland’s Cannabis Policy Oversight Team, member of Oregon’s Psilocybin Advisory Board, and board member for NuLeaf PDX; and also sits on several national boards including Cannabis Regulators of Color Coalition (CRCC), Doctors for Cannabis Regulation (DFCR), Minority Cannabis Business Association (MCBA), American Academy of Cannabinoid Medicine (AACM), and US Cannabis Council.

 

0
    0
    Your Cart
    Your cart is emptyReturn to Shop